{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:08:18Z","timestamp":1754399298913},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf03347910","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T11:44:27Z","timestamp":1396611867000},"page":"757-762","source":"Crossref","is-referenced-by-count":11,"title":["CV 205\u2013502 treatment of macroprolactinomas"],"prefix":"10.1007","volume":"14","author":[{"given":"B.","family":"Crottaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Uske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Brownell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"BF03347910_CR1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-100-1-78","volume":"100","author":"ML Vance","year":"1984","unstructured":"Vance M.L., Evans W.S., Thorner M.O. Diagnosis and treatment. Drugs five years later: bromocriptine. Ann. Intern. Med. 100: 78, 1984.","journal-title":"Ann. Intern. Med."},{"key":"BF03347910_CR2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJM198509123131103","volume":"313","author":"A Liuzzi","year":"1985","unstructured":"Liuzzi A., Dallabonzana D., Oppizzi G., Verde G.G., Cozzi R., Chiodini P., Luccarelli G. Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. N. Engl. J. Med. 313: 656, 1985.","journal-title":"N. Engl. J. Med."},{"key":"BF03347910_CR3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0015-0282(16)53154-9","volume":"52","author":"E Ciccarelli","year":"1989","unstructured":"Ciccarelli E., Miola C., Avataneo T., Camanni F., Besser G.M., Grossman A. Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR\u00ae, in patients with tumorous hyperprolactinemia. Fertil. Steril. 52: 930, 1989.","journal-title":"Fertil. Steril."},{"key":"BF03347910_CR4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1530\/acta.0.1220272","volume":"122","author":"A Kocijancic","year":"1990","unstructured":"Kocijancic A., Prezelj J., Vrhovec I., Lancranjan I. Parlodel LAR\u00ae in the treatment of macroprolactinomas. Acta Endocrinol. (Copenh) 122: 272, 1990.","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"BF03347910_CR5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","volume":"60","author":"ME Molitch","year":"1985","unstructured":"Molitch M.E., Elton R.L., Blackwell R.E., Caldwell B., Chang R.J., Jaffe R., Joplin G., Robbins R.J., Tyson J., Thorner M.O. and the Bromocriptine Study Group. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J. Clin. Endocrinol. Metab. 60: 698, 1985.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347910_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(88)91164-X","volume":"440","author":"A Closse","year":"1988","unstructured":"Closse A., Camps M., Wanner A., Palacios J.M. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H] CV 205\u2013502. Brain Res. 440: 123, 1988.","journal-title":"Brain Res."},{"key":"BF03347910_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2265.1987.tb00789.x","volume":"26","author":"C Rasmussen","year":"1987","unstructured":"Rasmussen C., Bergh T., Wide L., Brownell J. CV 205\u2013502: a new long-acting drug for inhibition of prolactin hypersecretion. Clin. Endocrinol. (Oxf.) 26: 321, 1987.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347910_CR8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/0024-3205(88)90301-3","volume":"43","author":"RC Gaillard","year":"1988","unstructured":"Gaillard R.C., Brownell J. Hormonal effects of CV 205\u2013502, a novel octahydrobenzo[g]quinoline with potent dopamine agonist properties. Life Sci. 43: 1355, 1988.","journal-title":"Life Sci."},{"key":"BF03347910_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jcem-68-2-336","volume":"68","author":"ML Vance","year":"1989","unstructured":"Vance M.L., Cragun J.R., Reimnitz C., Chang R.J., Rashef E., Blackwell R.E., Miller M.M., Molitch M.E. CV 205\u2013502 treatment of hyperprolactinemia. J. Clin. Endocrinol. Metab. 68: 336, 1989.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347910_CR10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0015-0282(16)60966-4","volume":"52","author":"PFM Heijden van der","year":"1989","unstructured":"van der Heijden P.F.M., Lappohn R.E., Corbey R.S., de Goeij W.B.K.M.V., Brownell J., Rolland R. The effectiveness, safety, and tolerability of CV 205\u2013502 in hyperprolactinemic women: a 12-month study. Fertil. Steril. 52: 574, 1989.","journal-title":"Fertil. Steril."},{"key":"BF03347910_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1988.tb01225.x","volume":"29","author":"C Rasmussen","year":"1988","unstructured":"Rasmussen C., Bergh T., Wide L., Brownell J. Long-term treatment with a new non-ergot long-acting dopamine agonist, CV 205\u2013502, in women with hyperprolactinaemia. Clin. Endocrinol. (Oxf.). 29: 271, 1988.","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"BF03347910_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1989.tb01263.x","volume":"31","author":"CB Newman","year":"1989","unstructured":"Newman C.B., Hurley A.M., Kleinberg D.L. Effect of CV 205\u2013502 in hyperprolactinaemic patients intolerant of bromocriptine. Clin. Endocrinol. (Oxf.). 31: 391, 1989.","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"BF03347910_CR13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2265.1990.tb00899.x","volume":"32","author":"R Homburg","year":"1990","unstructured":"Homburg R., West C., Brownell J., Jacobs H.S. A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205\u2013502, with bromocriptine in women with hyperprolactinaemia. Clin. Endocrinol. (Oxf.). 32: 565, 1990.","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"BF03347910_CR14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jcem-71-2-354","volume":"71","author":"Y Khalfallah","year":"1990","unstructured":"Khalfallah Y., Claustrat B., Grochowicki M., Flocard F., Horlait S., Serusclat P., Sassolas G. Effects of new prolactin inhibitor, CV 205\u2013502, in the treatment of human macroprolactinomas. J. Clin. Endocrinol. Metab. 71: 354, 1990.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347910_CR15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2265.1990.tb03900.x","volume":"33","author":"JW Verlaat Van\u2019t","year":"1990","unstructured":"Van\u2019t Verlaat J.W., Croughs R.J.M., Brownell J. Treatment of macroprolactinomas with a new non-ergot, long-acting dopaminergic drug, CV 205\u2013502. Clin. Endocrinol. (Oxf.) 33: 619, 1990.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347910_CR16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem-71-3-682","volume":"71","author":"O Serri","year":"1990","unstructured":"Serri O., Beauregard H., Lesage J., Pedneault L., Comtois R., Jilwan N., Somma M., Vachon L., Brownell J. Long term treatment with CV 205\u2013502 in patients with prolactin-secreting pituitary macroadenomas. J. Clin Endocrinol. Metab. 71: 682, 1990.","journal-title":"J. Clin Endocrinol. Metab."},{"key":"BF03347910_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2265.1990.tb00495.x","volume":"33","author":"PS Barnett","year":"1990","unstructured":"Barnett P.S., Dawson J.M., Butler J., Coskeran P.B., Maccabe J.J., McGregor A.M. CV 205\u2013502, a new non-ergot dopamine agonist, reduces prolactinoma size in man. Clin. Endocrinol. (Oxf.) 33: 307, 1990.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347910_CR18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7326\/0003-4819-112-9-668","volume":"112","author":"ML Vance","year":"1990","unstructured":"Vance M.L., Lipper M., Klibanski A., Biller B.M., Samaan N.A., Molitch M.E. Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205\u2013502. Ann. intern. Med. 112: 668, 1990.","journal-title":"Ann. intern. Med."},{"key":"BF03347910_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2265.1991.tb01731.x","volume":"34","author":"L Duranteau","year":"1991","unstructured":"Duranteau L., Chanson P., Lavoinne A., Horlait S., Lubetzki J., Kuhn J.M. Effect of the new dopaminergic agonist CV 205\u2013502 on plasma prolactin levels and tumor size in bromocriptine-resistant prolactinomas. Clin. Endocrinol. (Oxf.) 34: 25, 1991.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347910_CR20","first-page":"187","volume-title":"Magnetic resonance imaging of the central nervous system","author":"W Kucharczyk","year":"1987","unstructured":"Kucharczyk W. The pituitary gland and sella turcica. In: Brant-Zawadzki M., Norman D. (Eds), Magnetic resonance imaging of the central nervous system. Raven Press, New York, 1987, p. 187."},{"key":"BF03347910_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03350151","volume":"11","author":"F Rey","year":"1988","unstructured":"Rey F, Valterio C., Locatelli L., Ramelet A.A., Felber J.P. Lack of endocrine systemic side effects after topical application of spironolactone in man. J. Endocrinol. Invest. 11: 273, 1988.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03347910_CR22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jcem-69-3-500","volume":"69","author":"I Pellegrini","year":"1989","unstructured":"Pellegrini I., Rasolonjanahary R., Gunz G., Delivet B.S., Jedynak C.P., Kordon C., Peilion F., Jaquet P., Enjalbert A. Resistance to bromocriptine in prolactinomas. J. Clin. Endocrinol. Metab. 69: 500, 1989.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347910\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:32:36Z","timestamp":1565332356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF03347910"],"URL":"https:\/\/doi.org\/10.1007\/bf03347910","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}